1. Determining the antiviral activity of tenofovir disoproxil fumarate in treatment-naive chronically HIV-1-infected individuals;Louie;AIDS,2003
2. TDF-3TC-NVP is inferior to AZT-3TC-NVP in a large ART program in Nigeria [abstract];Scarsi,2010
3. Clinical and virologic outcomes of six first-line regimens in a large ART program in Nigeria;Darin,2010
4. Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the DAYANA Trial, IMEA032/ANRS12115;Landman,2011
5. Clinical and lipometabolic outcome of nevirapine- vs efavirenz-initial antiretroviral therapy, both with TDF/FTC-backbone;Stephan,2009